Blood Cancers Completed Phase 2 Trials for Melphalan (DB01042)

Also known as: Blood Cancer

IndicationStatusPhase
DBCOND0048268 (Blood Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00185614Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple MyelomaTreatment